₹1,017 to ₹17,899: Mukul Agrawal & Vijay Kedia stock that delivered 1644% returns in 2 Years

In recent months, the pharmaceutical industry has seen significant growth, with Neuland Laboratories Ltd. emerging as a standout performer. Having been undervalued at around Rs. 1,017 two years ago, the company has delivered an astonishing return of 1,655%.  Prominent ace investors such as Mukul Mahavir Agrawal and Vijay Kedia have acknowledged its potential, reinforcing Neuland’s … Continue reading ₹1,017 to ₹17,899: Mukul Agrawal & Vijay Kedia stock that delivered 1644% returns in 2 Years